Li Wang

3PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 25, 2025
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study.

Lingfang Xia, Keqiang Zhang, Ying Tang

|Feb 19, 2024
Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study.

Hanmei Lou, Hongbing Cai, Xin Huang

|Sep 22, 2022
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study.

Jusheng An, Jie Tang, Benjamin X Li

Pageof 1

Frequent Collaborators

2 joint publications

Guiling Li

1 joint publications

Jusheng An

1 joint publications

Jie Tang

1 joint publications

Benjamin X Li